NetworkNewsBreaks

WednesdayJan 17, 2024 1:54 pm

NetworkNewsBreaks – HUB Cyber Security Ltd. (NASDAQ: HUBC) Announced Seasoned Veteran as New CTO

HUB Cyber Security (NASDAQ: HUBC), a developer of confidential computing cybersecurity solutions and services, has named a new chief technology officer. According to the announcement, the strategic appointment of Nachman Geva as CTO “is meticulously crafted to position HUB Security at the forefront of the cybersecurity for the data fabric market, leveraging Geva's proven high-tech data analytics expertise and stellar track record.” Geva has more than 20 years of leadership experience in high-tech data analytics, including guiding key teams, launching successful software products, and excelling in big data applications, analytics, search, data warehousing, IoT and data integration. The company’s management…

Continue Reading

WednesdayJan 17, 2024 9:54 am

NetworkNewsBreaks – GEMXX Corporation (GEMZ) Announces Participation at Sequire Investor Summit in Puerto Rico

GEMXX (OTC: GEMZ), a leader in the ammolite gemstone mine-to-market segment, will be presenting at this month’s Sequire Investor Summit 2024. Sequire Investor Summit: Puerto Rico is slated for Jan. 23–25, 2024, in San Juan. According to the announcement, the three-day event is designed to provide an array of exciting opportunities for funds, companies and investors. The event agenda features more than 40 presentations from leading public companies as well as panel discussions and interactive sessions focused on addressing the latest trends and innovations in investor relations and technology. Puerto Rico was chosen as the site because it is home…

Continue Reading

TuesdayJan 16, 2024 4:03 pm

NetworkNewsBreaks – Upstream to Shine the Spotlight on the Future of Market Dynamics in Microcap Conference 2024

A recent blog written by Fernanda De La Torre highlights that Upstream will be sponsoring and meeting with issuers at The Microcap Conference. The event is slated to take place Jan. 30 through Feb. 1, 2024, in Atlantic City, New Jersey. The piece reads, “Members of the Upstream team will be in attendance to answer questions on why issuers should dual list on Upstream. We’ll have a dedicated booth where you can discover the opportunities of reaching a global audience through dual listing on Upstream’s next-generation market and trading app. We’re looking forward to connecting with U.S. and international issuers…

Continue Reading

TuesdayJan 16, 2024 3:47 pm

NetworkNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) ‘Ready to Challenge’ with New Five RS SUV, Reports ‘Road Track’ Article

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, and its Mullen Five RS were spotlighted in a recent “Road Track” article. The article noted that the sporty new model, which was revealed at CES 2024, is “ready to challenge Tesla and Lucid in the performance EV space. . . . Known as the Mullen Five RS, this electric crossover promises to bring over 1000 hp and a sub-2.0-second 0-60 mph sprint.” The article provided a background look at Mullen, which was incorporated in 2014 and comprises pieces of Coda Motor Cars and Mullen Motors. Calling the Five RS…

Continue Reading

TuesdayJan 16, 2024 3:35 pm

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Announces New Project Win with Well-Known Tracking-Solutions Partner

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has been awarded a new project with a well-known Canadian industry partner in the tracking-solutions sector. SuperCom announced the new project, noting that it marks another milestone in the company’s journey, “building on the company’s successful history of delivering top-tier services and technologies.” Revenue generation from the new contract is anticipated to start in Q1 2024. According to the announcement, the new project “represents a new chapter in SuperCom’s long-standing collaboration with this partner, transitioning from successful collaboration for providing RF-based tracking…

Continue Reading

TuesdayJan 16, 2024 3:27 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Provides Update on Litigation

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today provided an update regarding its litigation with GBB Drink Lab Inc. (“GBB”). In May 2023, GBB filed a lawsuit against FSD Pharma alleging a material breach of a mutual nondisclosure agreement and trade secret misappropriation. FSD Pharma has categorically denied these allegations and filed a motion to dismiss the lawsuit. On Jan. 8, 2024, the court denied the motion to dismiss, which means only that FSD Pharma will now proceed with discovery. The company is confident that…

Continue Reading

TuesdayJan 16, 2024 3:14 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Extensive GLP-1 Study Program

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today unveiled a comprehensive planned applied research program to thoroughly evaluate DehydraTECH for the improved delivery of GLP-1 drugs, designed to support prospective commercial partnering with global pharmaceutical companies. In a recent human pilot study with seven volunteers, Lexaria demonstrated superior pharmacokinetic (“PK”) oral delivery performance of the DehydraTECH-enhanced glucagon-like peptide-1 (“GLP-1”) drug semaglutide, available commercially in the branded product Rybelsus(R). The positive results were sufficient to encourage a much more thorough and expanded investigation. The objective of the new planned studies, as detailed in the announcement, is…

Continue Reading

TuesdayJan 16, 2024 2:53 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Third-Quarter 2024 Financial Report

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting on its financial results for the third quarter of fiscal 2024, the period ended Nov. 30, 2023. Numbers to note from the report include quarterly revenue of $6.14 million, which includes the company’s SMS & MMS, Telecommunications Products & Services businesses as well as Big Data, totaled $5.26 million, or 46% decrease, compared to Q3 2023; a quarterly decrease in Telecommunications Products & Services business revenue of $4.22 million or 41% compared to Q3 2023; quarterly Big Data revenue of $.01 million compared to $.19 million in Q3 2023;…

Continue Reading

TuesdayJan 16, 2024 2:39 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Business Update, Milestones

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, today outlined key accomplishments from 2023 and provided key strategic priorities for 2024. “In 2023, we experienced significant progress in both InMed’s pharmaceutical drug development and in BayMedica’s health and wellness initiatives. Our primary accomplishments throughout the year included a number of key milestones, such as the completion of a phase 2 clinical trial and the launch of two new preclinical programs targeting the treatment of Alzheimer’s disease and age-related macular degeneration (‘AMD’),” said Eric A. Adams, InMed president and CEO.…

Continue Reading

TuesdayJan 16, 2024 2:30 pm

NetworkNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released a message for its shareholders from CEO Mark Dybul. In the message, Dybul provides an update about key developments the company experienced during 2023, including signing a definitive agreement to combine with the European-based, cutting-edge artificial-intelligence (“AI”) company GEDi Cube; GEDi Cube’s partnership with NVIDIA to expand its multiomic capabilities to multimodal; and consistently achieving “the holy grail of cancer research” in preclinical studies. The company has also scheduled a shareholder meeting on Jan. 25, 2024, to vote…

Continue Reading